Acceder

Publicaciones - HEMATOLOGÍA Y ONCOLOGÍA MÉDICA CLÍNICO-EXPERIMENTAL

Cargando...
Alvarez-Larran A, Garrote M, Ferrer-Marin F, Perez-Encinas M, Mata-Vazquez MI, Bellosillo B, Arellano-Rodrigo E, Gomez M, Garcia R, Garcia-Gutierrez V, Gasior M, Cuevas B, Angona A, Gomez-Casares MT, Martinez CM, Magro E, Ayala R, Del Orbe-Barreto R, Perez-Lopez R, Fox ML, Raya JM, Guerrero L, Garcia-Hernandez C, Caballero G, Murillo I, Xicoy B, Ramirez MJ, Carreno-Tarragona G, Hernandez-Boluda JC, Pereira A; MPN Spanish Group (Grupo Espanol de Enfermedades Mieloproliferativas Filadelfia Negativas). Real-world analysis of main clinical outcomes in patients with polycythemia vera treated with ruxolitinib or best available therapy after developing resistance/intolerance to hydroxyurea. Cancer. 2022 Jul 1;128(13):2441-2448. doi: 10.1002/cncr.34195. Epub 2022 Apr 13. PubMed PMID: 35417564; PubMed Central PMCID: PMC9324831.
AÑO: 2022; IF: 6.2
35417564
Puiggros A, Ramos-Campoy S, Kamaso J, de la Rosa M, Salido M, Melero C, Rodriguez-Rivera M, Bougeon S, Collado R, Gimeno E, Garcia-Serra R, Alonso S, Moro-Garcia MA, Garcia-Malo MD, Calvo X, Arenillas L, Ferrer A, Mantere T, Hoischen A, Schoumans J, Espinet B. Optical Genome Mapping: A Promising New Tool to Assess Genomic Complexity in Chronic Lymphocytic Leukemia (CLL). Cancers (Basel). 2022 Jul 11;14(14):3376. doi: 10.3390/cancers14143376. PubMed PMID: 35884436; PubMed Central PMCID: PMC9317182.
AÑO: 2022; IF: 6.575
35884436
Vilorio-Marques L, Castanon Fernandez C, Mora E, Gutierrez L, Rey Bua B, Jimenez Lorenzo MJ, Diaz Beya M, Vara Pampliega M, Molero A, Sanchez-Garcia J, Calabuig M, Cedena MT, Chen-Liang T, Diaz Santa JA, Padilla I, Hernandez F, Diez R, Asensi P, Xicoy B, Sanz G, Valcarcel D, Diez-Campelo M, Bernal T. Relevance of infections on the outcomes of patients with myelodysplastic syndromes, chronic myelomonocytic leukemia, and acute myeloid leukemia treated with hypomethylating agents: a cohort study from the GESMD. Ther Adv Hematol. 2022 Sep 29;13:20406207221127547. doi: 10.1177/20406207221127547. eCollection 2022. PubMed PMID: 36199837; PubMed Central PMCID: PMC9527993.
AÑO: 2022; IF: 3.4
36199837
Carmona-Bayonas A, Jimenez-Fonseca P, Gallego J, Msaouel P. Causal Considerations Can Inform the Interpretation of Surprising Associations in Medical Registries. Cancer Invest. 2022 Jan;40(1):1-13. doi: 10.1080/07357907.2021.1999971. Epub 2021 Nov 25. PubMed PMID: 34709109.
AÑO: 2022; IF: 2.4
34709109
Zaragoza-Huesca D, Nieto-Olivares A, Garcia-Molina F, Ricote G, Montenegro S, Sanchez-Canovas M, Garrido-Rodriguez P, Penas-Martinez J, Vicente V, Martinez F, Lozano ML, Carmona-Bayonas A, Martinez-Martinez I. Implication of Hepsin from Primary Tumor in the Prognosis of Colorectal Cancer Patients. Cancers (Basel). 2022 Jun 24;14(13):3106. doi: 10.3390/cancers14133106. PubMed PMID: 35804878; PubMed Central PMCID: PMC9264764.
AÑO: 2022; IF: 6.575
35804878
< AnteriorSiguiente >
IMIB-Arrixaca

Instituto de Investigación Sanitaria Acreditado

ISCII

HEMATOLOGÍA Y ONCOLOGÍA MÉDICA CLÍNICO-EXPERIMENTAL